MA
Maricel Apuli sold $146K of BBIO stock
Maricel Apuli, Chief Accounting Officer of BridgeBio Pharma, Inc. (BBIO), sold 2,000 shares of BBIO stock worth $146K, per an SEC Form 4 filed Nov 3, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 30, 2026, 4 days before it was made public.
BBIO has moved +4.0% since the trade date, from $74.95 to $77.93 (Nov 9, 2026 close).
- Traded
- Oct 30, 2026
- Disclosed
- Nov 3, 2026
- Filing delay
- 4 days
- Price since
- +4.0%
- Role
- Chief Accounting Officer
- Source
- SEC Form 4